CG Oncology, Inc.

Developing an oncolytic immunotherapy program for non-muscle invasive bladder cancer across multiple disease settings.

Back to company catalog

Oncology / bladder cancer · Oncolytic immunotherapy · Late clinical (Phase 3)

Compare report options